Drug recall · January 13, 2021
labetalol HCl 20 mg/4 mL recall
Why: Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
labetalol HCl 20 mg/4 mL, Injection for Intravenous Use (5mg/mL), Rx Only, 4 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004070028
- Lots / codes
Lot # 1220022969, BUD 3/1/2021; 1220023002, BUD 3/2/2021; 1220023045, BUD 3/2/2021; 1220023081, BUD 3/2/2021; 1220023130, BUD 3/6/2021; 1220023229, BUD 3/9/2021; 1220023287, BUD 3/12/2021 & 1220023335, BUD 3/22/2021.
- Quantity
- 9,057 syringes
- Company
- SCA Pharmaceuticals, Windsor, CT
- Distribution
- Product was distributed to hospitals nationwide.
- Initiated
- December 17, 2020 · Voluntary: Firm initiated
- Classified
- January 7, 2021
- Reported
- January 13, 2021
- Ended
- November 2, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Labetalol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.